Kentucky-based St. Elizabeth Medical Center Inc. and Summit Medical Group Inc. defeated a whistleblower’s attempt to reinstate a False Claims Act suit alleging they charged health-care programs for unnecessary kidney and vascular procedures, the Sixth Circuit said Friday.

Drug compounders seeking to produce peptides are stepping into an unclear regulatory zone as the FDA reconsiders restrictions over the products that have gained popularity among wellness influencers.

A California jury incorrectly found that two doctors stole trade secrets, breached a contract, and took improper credit for inventions related to the cosmetic penile implant business of International Medical Devices Inc., the Federal Circuit ruled Friday.

A group of transgender women couldn’t convince a split federal appeals court to affirm court orders to stop their transfer to male prisons under a Trump executive order.

Labratory Corp. of America agreed to an injunction that will limit its use of online tracking tools that allegedly sent sensitive information to third parties for at least two years, according to a motion to preliminarily approve a settlement.

Sarepta Therapeutics Inc.'s bid for the full Federal Circuit’s review of a revived gene-therapy patent dispute with RegenxBio Inc. is drawing new attention to the question of when altered DNA becomes different enough from nature to be patented.